Cofepris issues alert over adulterated Aderogyl and falsified medications

Mexico's Federal Commission for Protection against Sanitary Risks (Cofepris) has issued a health alert regarding the adulteration and falsification of several medications, including the vitamin supplement Aderogyl (Retinol, Ascorbic Acid, Ergocalciferol). Sanofi Aventis, the registration holder, identified anomalies in specific batches of Aderogyl, specifically batches CMXA036 and CMXA037. In batch CMXA036, expiration dates were missing, while batch CMXA037 showed altered expiration dates. Because the identity, purity, and efficacy of these batches cannot be guaranteed, their use poses a health risk.

In addition to Aderogyl, authorities have raised concerns regarding the falsification of Darzalex and Simponi. Health officials are urging the public to avoid purchasing medications through informal channels, such as street markets or unverified internet platforms, particularly during seasonal temperature changes.

Consumers are advised to purchase only from authorized distributors and established pharmacies. It is recommended to inspect packaging for signs of tampering and to ensure that lot numbers and expiration dates are clearly visible and unaltered. Using counterfeit or adulterated products can lead to serious health complications, including liver, kidney, and neurological damage.